Allarity Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Allarity Therapeutics, Inc. (ALLR) reported Increase (Decrease) in Prepaid Expense of $1.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$124.00K, a 114.35% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $1.39M.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $314.00K, a 11.80% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $439.00K.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2025 was $1.60M.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$274.00K, a 244.21% decline from fiscal 2023.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $190.00K, a 69.26% decline from fiscal 2022.
- Allarity Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $618.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.27M 10-Q · filed 2026-08-14 | $1.58M derived: sum of 3 quarters · filed 2026-08-14 | $2.02M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.39M 10-Q · filed 2026-05-15 | $1.71M derived: sum of 2 quarters · filed 2026-05-15 | $2.14M derived: sum of 3 quarters · filed 2026-05-15 | $3.01M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $753.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.62M derived: sum of 3 quarters · filed 2026-08-14 | $1.60M 10-K · filed 2026-03-30 |
| 2025-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.30M derived: sum of 2 quarters · filed 2026-08-14 | $1.29M 10-Q · filed 2025-11-14 | $1.65M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $850.00K 10-Q · filed 2026-08-14 | $1.21M derived: sum of 3 quarters · filed 2026-08-14 | $991.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$14.00K 10-Q · filed 2026-05-15 | $342.00K derived: sum of 2 quarters · filed 2026-05-15 | $127.00K derived: sum of 3 quarters · filed 2026-05-15 | -$49.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $141.00K derived: sum of 2 quarters · filed 2026-03-30 | -$35.00K derived: sum of 3 quarters · filed 2026-03-30 | -$274.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$391.00K derived: sum of 2 quarters · filed 2025-11-14 | -$630.00K 10-Q · filed 2025-11-14 | -$245.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$415.00K 10-Q · filed 2025-08-15 | -$30.00K derived: sum of 3 quarters · filed 2025-08-15 | $146.00K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | -$239.00K 10-Q · filed 2025-05-09 | $146.00K derived: sum of 2 quarters · filed 2025-05-09 | $322.00K derived: sum of 3 quarters · filed 2025-05-09 | -$55.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $561.00K derived: sum of 2 quarters · filed 2025-03-31 | $184.00K derived: sum of 3 quarters · filed 2025-03-31 | $190.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$201.00K derived: sum of 2 quarters · filed 2024-11-14 | -$195.00K 10-Q · filed 2024-11-14 | -$79.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$377.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$371.00K 10-Q · filed 2024-08-05 | -$255.00K derived: sum of 3 quarters · filed 2024-08-05 | -$640.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-14 | $122.00K derived: sum of 2 quarters · filed 2024-05-14 | -$263.00K derived: sum of 3 quarters · filed 2024-05-14 | -$603.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$269.00K derived: sum of 2 quarters · filed 2024-03-08 | -$609.00K derived: sum of 3 quarters · filed 2024-03-08 | $618.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | -$385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$725.00K derived: sum of 2 quarters · filed 2023-11-14 | $502.00K 10-Q · filed 2023-11-14 | $421.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $887.00K 10-Q · filed 2023-08-14 | $806.00K derived: sum of 3 quarters · filed 2023-08-14 | $913.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.23M 10-Q · filed 2023-05-11 | $1.15M derived: sum of 2 quarters · filed 2023-05-11 | $1.25M derived: sum of 3 quarters · filed 2023-05-11 | $1.25M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $26.00K derived: sum of 2 quarters · filed 2023-03-13 | $25.00K derived: sum of 3 quarters · filed 2023-03-13 | -$130.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $106.00K derived: sum of 2 quarters · filed 2022-11-14 | -$49.00K 10-Q · filed 2022-11-14 | -$314.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | -$156.00K 10-Q · filed 2022-10-07 | -$421.00K derived: sum of 3 quarters · filed 2022-10-07 | |
| 2021-03-31 | -$155.00K 10-Q · filed 2022-05-27 | -$420.00K derived: sum of 2 quarters · filed 2022-05-27 | ||
| 2020-12-31 | -$265.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$97.00K 10-K · filed 2022-05-17 | ||
| 2020-09-30 | $168.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |